Therapeutic targeting of autophagy in disease: Biology and pharmacology

Yan Cheng, Xingcong Ren, William N. Hait, Jin Ming Yang

Research output: Contribution to journalReview article

120 Citations (Scopus)

Abstract

Autophagy, a process of self-digestion of the cytoplasm and organelles through which cellular components are recycled for reuse or energy production, is an evolutionarily conserved response to metabolic stress found in eukaryotes from yeast to mammals. It is noteworthy that autophagy is also associated with various pathophysiologic conditions in which this cellular process plays either a cytoprotective or cytopathic role in response to a variety of stresses such as metabolic, inflammatory, neurodegenerative, and therapeutic stress. It is now generally believed that modulating the activity of autophagy through targeting specific regulatory molecules in the autophagy machinery may impact disease processes, thus autophagy may represent a new pharmacologic target for drug development and therapeutic intervention of various human disorders. Induction or inhibition of autophagy using small molecule compounds has shown promise in the treatment of diseases such as cancer. Depending on context, induction or suppression of autophagy may exert therapeutic effects via promoting either cell survival or death, two major events targeted by therapies for various disorders. A better understanding of the biology of autophagy and the pharmacology of autophagy modulators has the potential for facilitating the development of autophagy-based therapeutic interventions for several human diseases.

Original languageEnglish (US)
Pages (from-to)1162-1197
Number of pages36
JournalPharmacological Reviews
Volume65
Issue number4
DOIs
StatePublished - Oct 1 2013

Fingerprint

Autophagy
Pharmacology
Therapeutics
Physiological Stress
Therapeutic Uses
Eukaryota
Organelles
Digestion
Mammals
Cell Survival
Cytoplasm
Cell Death
Yeasts

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Pharmacology

Cite this

Cheng, Yan ; Ren, Xingcong ; Hait, William N. ; Yang, Jin Ming. / Therapeutic targeting of autophagy in disease : Biology and pharmacology. In: Pharmacological Reviews. 2013 ; Vol. 65, No. 4. pp. 1162-1197.
@article{94bd65b6f2c2424db607b66bde54b35b,
title = "Therapeutic targeting of autophagy in disease: Biology and pharmacology",
abstract = "Autophagy, a process of self-digestion of the cytoplasm and organelles through which cellular components are recycled for reuse or energy production, is an evolutionarily conserved response to metabolic stress found in eukaryotes from yeast to mammals. It is noteworthy that autophagy is also associated with various pathophysiologic conditions in which this cellular process plays either a cytoprotective or cytopathic role in response to a variety of stresses such as metabolic, inflammatory, neurodegenerative, and therapeutic stress. It is now generally believed that modulating the activity of autophagy through targeting specific regulatory molecules in the autophagy machinery may impact disease processes, thus autophagy may represent a new pharmacologic target for drug development and therapeutic intervention of various human disorders. Induction or inhibition of autophagy using small molecule compounds has shown promise in the treatment of diseases such as cancer. Depending on context, induction or suppression of autophagy may exert therapeutic effects via promoting either cell survival or death, two major events targeted by therapies for various disorders. A better understanding of the biology of autophagy and the pharmacology of autophagy modulators has the potential for facilitating the development of autophagy-based therapeutic interventions for several human diseases.",
author = "Yan Cheng and Xingcong Ren and Hait, {William N.} and Yang, {Jin Ming}",
year = "2013",
month = "10",
day = "1",
doi = "10.1124/pr.112.007120",
language = "English (US)",
volume = "65",
pages = "1162--1197",
journal = "Pharmacological Reviews",
issn = "0031-6997",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "4",

}

Therapeutic targeting of autophagy in disease : Biology and pharmacology. / Cheng, Yan; Ren, Xingcong; Hait, William N.; Yang, Jin Ming.

In: Pharmacological Reviews, Vol. 65, No. 4, 01.10.2013, p. 1162-1197.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Therapeutic targeting of autophagy in disease

T2 - Biology and pharmacology

AU - Cheng, Yan

AU - Ren, Xingcong

AU - Hait, William N.

AU - Yang, Jin Ming

PY - 2013/10/1

Y1 - 2013/10/1

N2 - Autophagy, a process of self-digestion of the cytoplasm and organelles through which cellular components are recycled for reuse or energy production, is an evolutionarily conserved response to metabolic stress found in eukaryotes from yeast to mammals. It is noteworthy that autophagy is also associated with various pathophysiologic conditions in which this cellular process plays either a cytoprotective or cytopathic role in response to a variety of stresses such as metabolic, inflammatory, neurodegenerative, and therapeutic stress. It is now generally believed that modulating the activity of autophagy through targeting specific regulatory molecules in the autophagy machinery may impact disease processes, thus autophagy may represent a new pharmacologic target for drug development and therapeutic intervention of various human disorders. Induction or inhibition of autophagy using small molecule compounds has shown promise in the treatment of diseases such as cancer. Depending on context, induction or suppression of autophagy may exert therapeutic effects via promoting either cell survival or death, two major events targeted by therapies for various disorders. A better understanding of the biology of autophagy and the pharmacology of autophagy modulators has the potential for facilitating the development of autophagy-based therapeutic interventions for several human diseases.

AB - Autophagy, a process of self-digestion of the cytoplasm and organelles through which cellular components are recycled for reuse or energy production, is an evolutionarily conserved response to metabolic stress found in eukaryotes from yeast to mammals. It is noteworthy that autophagy is also associated with various pathophysiologic conditions in which this cellular process plays either a cytoprotective or cytopathic role in response to a variety of stresses such as metabolic, inflammatory, neurodegenerative, and therapeutic stress. It is now generally believed that modulating the activity of autophagy through targeting specific regulatory molecules in the autophagy machinery may impact disease processes, thus autophagy may represent a new pharmacologic target for drug development and therapeutic intervention of various human disorders. Induction or inhibition of autophagy using small molecule compounds has shown promise in the treatment of diseases such as cancer. Depending on context, induction or suppression of autophagy may exert therapeutic effects via promoting either cell survival or death, two major events targeted by therapies for various disorders. A better understanding of the biology of autophagy and the pharmacology of autophagy modulators has the potential for facilitating the development of autophagy-based therapeutic interventions for several human diseases.

UR - http://www.scopus.com/inward/record.url?scp=84888161072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888161072&partnerID=8YFLogxK

U2 - 10.1124/pr.112.007120

DO - 10.1124/pr.112.007120

M3 - Review article

C2 - 23943849

AN - SCOPUS:84888161072

VL - 65

SP - 1162

EP - 1197

JO - Pharmacological Reviews

JF - Pharmacological Reviews

SN - 0031-6997

IS - 4

ER -